Such pharmaceutical compositions may further comprise acetylcholine, acetylcholine-like compounds or analogs, or other agents which enhance or otherwise increase the amount or concentration of acetylcholine at or near acetylcholine receptors, for instance acetyl-cholinesterase inhibitors.